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Recessive EKV
To the Editor:
Thank you for communicating to us Doctors van Steensel
and van Geel’s letter expressing their concern on our re-
cently published letter in JID (Terrinoni et al, 2004) entitled
‘‘A novel recessive connexin 31 (GJB3) mutation in a case of
erythrokeratodermia variabilis’’.
In this letter, van Steensel and van Geel were uncon-
vinced by the possibility of the existence of an autosomal
recessive erythrokeratodermia variabilis (EKV).
Their argument and concern for our published data were
based on the following major points.
They claim (1) that the clinical pictures presented in our
paper would be more consistent with the diagnosis of
epidermolytic hyperkeratosis (EH) with cyclic ichthyosis
(Sybert et al, 1999), rather than EKV. (2) The histological fea-
tures shown in our paper (Terrinoni et al, 2004, Fig 1c) show
the presence of epidermolysis in the suprabasal layer of ep-
idermis that should not be reported in EKV. (3) A keratin K1
mutation could be involved in the generation of this particular
phenotype of our patient. (4) Therefore, we may need to con-
firm that our mutation in connexin excludes the possibility that
this hetherozygous substitution could be a genetic poly-
morphism. (5) Mutations of connexin proteins generally give
rise to trans-dominant effects, with a gain of function effect.
In order to answer to all these queries, we reanalyzed our
patient both at the clinical and at the molecular levels.
Regarding point 1, the clinical anamnesis of the patient,
the analysis of the first medical report, and parents’ inter-
view revealed that skin blistering had never been observed
from birth to the presentation of erythematous and hyperke-
ratotic symptoms. The patient’s clinical features and the
disease course during treatment with acitretin (see Terrinoni
et al, 2004) are consistent with the diagnosis of EKV.
We performed new histological examination of the pa-
tient (point 2) compared with that of a patient carrying the
Keratin K1 I479T mutation. The histological examination
(Fig 1, panels A and C) clearly shows the presence of ep-
idermal hyperplasia (also in Fig 1c (left and right parts) of
Terrinoni et al, 2004) without signs of epidermolysis, which is
widely present in the upper layers of the EH (Fig 1B and D,
asterisks). Furthermore, in the histology, hyperkeratosis of
the stratum corneum with the characteristic basket wave
conformation (Fig 1A, black arrows) is visible, whereas EH is
characterized by a more compact stratum corneum (Fig 1B
and D, blue arrows). Moreover, keratohyalin granules could
not be observed in the upper layer of the epidermis which
are typical of EH (see arrowhead in Fig 1B and D). Alto-
gether, these findings strongly support an EKV histology.
Furthermore, regarding point 3, sequencing of the entire
K1 coding region resulted in a fully functional normal gene,
thus definitively discarding the hypothesis that a defect
in this keratin is responsible for the patient phenotype
(Fig 1E). Moreover, our group has previously reported
(Terron-Kwiatkowski et al, 2004) two families that carry the
isoleucine 479 substitution described by Sybert et al, but
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Figure1
Histology from erythrokeratodermia variabilis (EKV) and epi-
dermolytic hyperkeratosis (EH) patients. (A–D) Comparison of two
histological sections (hematoxylin/eosin stained). A, C from EKV pa-
tient. B, D from K1 I479T patient (EH). Presence of epidermal hype-
rplasia without signs of epidermolysis in A and high epidermolysis in
upper layers in B (asterisks), typical of EH patients. Furthermore, A and
C show hyperkeratosis of the stratum corneum with the characteristic
basket wave conformation (black arrows), whereas EH in B and C are
characterized by a more compact stratum corneum (blue arrows).
Moreover, keratohyalin granules could not be observed in the upper
layer of keratinocytes (A, C) whereas, again these are typical of EH
(arrowhead in B, D). E, keratin K1 sequence analysis. Chromatogram
showing the sequence of keratin K1 2B domain. The amino acid sub-
stitution found in EH with Cyclic Ichtyosis is indicated in red; no ab-
normal peaks are visible in the chromatogram, indicating that the
patient does not carry any mutation in this domain. The sequence of the
entire coding region is negative for the presence of other mutations
(data not shown).
Abbreviation: EH, epidermolytic hyperkeratosis; EKV, erythro-
keratodermia variabilis
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characterized only by the presence of palmoplantar
keratoderma. In those patients, the annular, polycyclic ery-
thematous plaques could not be observed in any of the
affected members. We also analyzed two sporadic patients
with the I479T mutation showing only light ichthyosis and
presence of PPK, again with no signs of erythrodermia
(personal communication), indicating once again that in
keratin mutations, a direct genotype–phenotype correlation
for keratin mutations is often difficult, and that the pheno-
type described by Sybert et al might be due to a peculiar
genetic background rather than a specific keratin mutation.
To address point 4, we showed previously (Fig 2A in our
JID paper) the pedigree for the mutation that originated from
a common ancestor. All the family members that we analy-
zed were wild type or heterozygous for the E100K mutation.
Furthermore, in order to exclude the possibility of a poly-
morphism in Cx31 gene, we tested 50 unrelated individuals
as standard control (100 alleles, with restriction analysis),
and we do not detect the presence of the mutation even in
heterozygosis.
In addition, we decided that some functional data on the
mutated protein would help to strengthen the message of
our previous paper. To do this, we decided to test the effect
of E100K mutation on the normal intracellular location of
connexin 31 and to also test its effect on the viability of
cultured cells. We expressed the mutant Cx31 fused with
red fluorescent protein, in transformed human epidermal
keratinocytes (HaCaT). Cells transfected using wild-type
Cx31 showed a classical punctate staining mainly at cell
junctions, suggesting a normal trafficking of the protein to
the plasma membrane (Fig 2A, B); the mutated Cx31 also
seems to form aggregates, but we have been unable to see
staining at the membrane junctions (Fig 2C, D). Further-
more, FACS analysis of transfected HaCaT cells showed an
increased of apoptosis upon transfection of the mutant all-
ele (Fig 2E, F). These findings confirm recent functional data
(Di et al, 2002; Diestel et al, 2002; Gottfried et al, 2002)
suggesting that cytoplasmic localization of mutated Cx31
can induce cell death and EKV.
In conclusion, our clinical, histological, and molecular
findings presented here and previously (Terron-Kwiatkowski
et al, 2004) strongly indicate the newly described recessive
mutation E100K in connexin 31 gene is responsible for EKV.
Moreover, the preliminary functional data presented here
suggest the possibility that abnormal localization of the
mutant Cx31 and the increased apoptosis observed in cells
overexpressing the mutant protein demonstrate a different
phenotype between the wild-type and mutant proteins.
These differences could support the possibility that this
mutation is causative of the disease.
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Figure 2
Expression of the Wt and mutant Cx31 fused with red fluorescent
protein. Cx31 fusion protein were expressed in transformed human
epidermal keratinocytes (HaCaT). (A, B) Cells transfected using wild-
type Cx31 showed a classical punctate staining mainly at cell junction
indicated by white arrows, suggesting a normal trafficking of the protein
to the plasma membrane. (C, D) mutated Cx31 fusion protein seems
form aggregates, but staining at the membrane junction (white arrows)
is not visible. (E, F, G) FACS analysis. (A) HaCaT cell transfected with
control vector. (B) Wt Cx31 transfection and (C) mutant E100K Cx31
transfection, showing a shifting from the basal apoptotic values from
the 17%–18% of gated cells to the 26% in the sample transfected with
the mutant E100K Cx31.
LETTER TO THE EDITOR 271124 : 1 JANUARY 2005
